Side effects of nintedanib: What are the common side effects, and what should we pay attention to for severe side effects?
Nintedanib (Nintedanib) is an oral tyrosine kinase inhibitor mainly used to treat idiopathic pulmonary fibrosis (IPF) and certain types of cancer (such as non-small cell lung cancer and ovarian cancer). As a targeted drug, nintedanib reduces the process of fibrosis by inhibiting the activity of multiple tyrosine kinases, and has achieved certain efficacy in the treatment of lung diseases and cancer. However, like many medications, nintedanib has some side effects that patients need to be aware of and manage while using it.
Common side effects
Side effects of nintedanib are often related to the drug's mechanism of action, particularly its inhibition of tyrosine kinases. Common side effects include:
1.Gastrointestinal discomfort: The most common side effects are gastrointestinal reactions, such as nausea, vomiting, diarrhea and loss of appetite. Approximately 30% to 40% of patients taking nintedanib experience these symptoms, especially early in treatment. Diarrhea is the most common gastrointestinal symptom and may lead to dehydration and weight loss, so patients need to pay close attention to these symptoms and adjust their diet and fluids in a timely manner.
2.Fatigue and weakness: Some patients experience ongoing fatigue or weakness, which may affect daily life and activity levels. This fatigue is often related to the antitumor or antifibrotic effects of the drug, but may also be due to the drug's effect on overall metabolism. Proper rest and management can relieve these symptoms.
3.Abnormal liver function: The use of nintedanib may cause damage to liver function. Common manifestations include elevated transaminases (such as elevated ALT and AST levels), and some patients may develop jaundice or hepatitis symptoms. Liver function abnormalities usually occur in the early stages of treatment, and patients should regularly monitor liver function indicators, especially in the first few months of treatment.
4. Hypertension: Some patients may develop hypertension when using nintedanib, especially those with poorly controlled blood pressure. Doctors will usually assess a patient's blood pressure before starting treatment and recommend monitoring it regularly during treatment. If blood pressure is elevated, medication adjustments or the addition of antihypertensive medications may be needed.
serious side effects
Although most side effects are mild or moderate, nintedanib may also cause some more serious side effects that patients need to pay special attention to:
1.Cardiovascular events: Nintedanib can sometimes cause serious cardiovascular events, especially if high blood pressure is not controlled, which may increase the risk of heart attack or stroke. Patients should seek medical attention promptly if symptoms such as chest pain, shortness of breath, or irregular heartbeat occur. Patients with a prior history of cardiovascular disease require close monitoring while using this drug.
2.Lung problems: Although nintedanib is used to treat pulmonary fibrosis, in some cases it may worsen lung disease, leading to worsening of acute respiratory distress syndrome (ARDS) or interstitial lung disease (ILD). If patients develop symptoms such as difficulty breathing, persistent cough, or chest pain, they should stop taking the drug immediately and seek medical evaluation.
3.Bleeding tendency: Nintedanib may cause mild to moderate bleeding problems, especially with long-term use. Some patients may experience nosebleeds, bleeding gums, or skin bruising. If the patient has obvious bleeding symptoms, such as a wound that cannot stop bleeding for a long time, he should seek medical treatment immediately.
4. Impaired renal function: Although rare, the use of nintedanib may have an impact on renal function, especially in patients with underlying renal disease. During use, patients should regularly monitor renal function indicators, especially renal tubular function and creatinine levels, in order to detect any abnormalities in time.
How to manage side effects
Regarding the side effects of nintedanib, there are steps patients can take to manage and reduce discomfort:
1.Relieve gastrointestinal reactions: During the treatment process, patients can adopt a low-fat, high-fiber diet and avoid greasy and irritating foods. At the same time, the diet should be divided into multiple meals to reduce the burden on the gastrointestinal tract. If diarrhea continues to be severe, you can use antidiarrheal drugs, such as loperamide (Loperamide), as recommended by your doctor, and maintain adequate fluid intake.
2.Regular monitoring of liver and kidney function: Patients need to have liver and kidney function checked regularly during treatment. If elevated transaminase levels or abnormal renal function are found, the drug dosage should be adjusted promptly or other treatment measures should be taken.
3. Blood pressure monitoring and management: Patients should monitor their blood pressure regularly, especially in the early stages of treatment. For patients with high blood pressure, antihypertensive medications may be needed during treatment. At the same time, excessive fatigue and mood swings should be avoided to reduce the impact on blood pressure.
4. Seek medical attention promptly and report side effects: If patients experience obvious side effects, especially symptoms such as severe bleeding, cardiovascular problems, or difficulty breathing, they should contact their doctor immediately for further evaluation and treatment.
As an effective anti-fibrotic drug, nintedanib has significant efficacy in the treatment of pulmonary fibrosis and certain types of cancer, but it also has a certain risk of side effects. Common side effects include gastrointestinal discomfort, fatigue, abnormal liver function and high blood pressure, while more serious side effects include cardiovascular events, lung problems, bleeding tendencies and impaired kidney function. Patients should pay close attention to these side effects during treatment, conduct relevant examinations regularly, and make reasonable management and adjustments according to the doctor's recommendations.
Reference materials:https://en.wikipedia.org/wiki/Nintedanib
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)